R Catlett-Falcone

STAT proteins as novel targets for cancer therapy. Signal transducer an activator of transcription.

R. Jove, W. Dalton, W S Dalton, 1999, Current opinion in oncology.

Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.

M. Jaroszeski, D. Coppola, Hua Yu, 1999, Cancer research.

Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression.

J. Turkson, R. Jove, Jin Hong Liu, 2001, The Journal of clinical investigation.